Progression from prediabetes to type 2 diabetes mellitus in Mexico. Evaluation in a cohort;Progresión de prediabetes a diabetes mellitus tipo 2 en mexicanos. Evaluación en una cohorte

Gaceta Medica de Mexico

Volumn 145, Issue 4, 2009, Pages 269-272

  Coronado Malagón, Martín ^a   Ivan Gomez Vargas J ^a   Espinoza Peralta, Diego ^a   Arce Salinas, Alejandro ^a  

^a HOSPITAL CENTRAL SUR DE ALTA ESPECIALIDAD   (Mexico)

Author keywords

Glucose intolerance; Hyperglycemia; Insulin resistance; Prediabetic state

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MALE; MEXICO; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEXICO; MIDDLE AGED; PREDIABETIC STATE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77449084312     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. King H, Aubert RE, Herman WH. Global burden of diabetes 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-31.
2. Aguilar-Salinas CA, Velázquez-Monroy O, Gómez-Pérez FJ, González-Chávez A, Esqueda AL, Molina-Cuevas V, et al. Characteristics of patients with type 2 diabetes in Mexico: Results from a large population based nationwide survey. Diabetes Care 2003;26:2021-2026.
3. Secretaría de Salud. Estadísticas vitales de México. 2007. Disponible en http://sinais.salud.gob.mx/descargas/xls/diezprincausasmort2007_CNEGySR.xls
4. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravossin F, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulindependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 1993;329:1988-1992.
5. Eldin WS, Emara M, Shoker A. Prediabetes: a must to recognise disease state. Int J Clin Pract 2008;62:642-648.
6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2007;30(Suppl 1):S42-S47.
7. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007;30:753-759.
8. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Llanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350.
9. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346: 393-403.
10. Rasmussen SS, Glümer C, Sandbaek A, Lauritzen T, Borch-Johnsen K. Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year followup in the ADDITION study, Denmark. Diabetologia 2008;51:249-257.
11. Ferrannini E, Massari M, Nannipieri M, Natali A, López-Ridaura R, González-Villalpando C. Plasma glucose levels as predictors of diabetes: The Mexico City diabetes study. Diabetologia 2009;52:818-824.
12. Chen KT, Chen CJ, Gregg EW, Imperatore G, Narayan KM. Impaired fasting glucose and risk of diabetes in Taiwan: follow-up over 3 years. Diabetes Res Clin Pract 2003;60:177-182.
13. Edelstein SL, Knowler WC, Bain RP, Andrés R, Barrett-Connor EL, Dowse GK, et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997;46:701-710.